logo

FDA Calendar

Share
Company Name Amgen Inc.
Drug Name ABP 798 (BLA)
Event Name FDA decision on ABP 798 (biosimilar rituximab) for Non-Hodgkin's lymphoma and Rheumatoid arthritis
Event Date 12/19/2020
Outcome Date
Outcome
Drug Status s
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar